Which of the following was NOT a key clinical characteristic of the DCB group in the AGENT IDE trial?

• A. Diabetes
• B. Prior MI
• C. Multiple stent layers
• D. Hypertension

Answer: (D)

The DCB (Drug-Coated Balloon) group in the AGENT IDE trial had specific clinical characteristics that were critical in understanding the patient population involved. Among these characteristics, diabetes, prior myocardial infarction (MI), and multiple stent layers were all significant factors associated with the patients in this group.

Diabetes is often linked to worse cardiovascular outcomes, and its presence in the DCB group suggests a patient population with more complex disease states. Prior MI also highlights a history of cardiac events, which can influence treatment strategies. Multiple stent layers indicate more extensive coronary artery disease and possibly a higher burden of vascular pathology, which directly relates to the necessity for advanced interventional techniques like those provided by drug-coated balloons.

In contrast, hypertension, while a common comorbidity in cardiovascular patients, was not highlighted as a key characteristic specific to the DCB group in this particular trial. Its absence from the emphasized clinical characteristics suggests that it did not distinctly define this particular cohort in the same way as the other three factors did. Thus, it is accurate to state that hypertension was not a key clinical characteristic of the DCB group in the AGENT IDE trial.